MedTrace Logo

Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries

NCT00773942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 637

Last updated 2019-07-24

No results posted yet for this study

Summary

The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.

Conditions

  • Chronic Illness
  • Adverse Effects
  • Medication Errors
  • Elderly Patients

Interventions

BEHAVIORAL

Basic medication therapy management

Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview alone.

BEHAVIORAL

Enhanced medication therapy management

Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview and chart information.

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Duke University

    collaborator OTHER

  • Baylor Research Institute

    collaborator OTHER

  • RTI International

    collaborator OTHER

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Daniel R Touchette, PharmD, MA · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00773942 on ClinicalTrials.gov